Abeona Therapeutics (ABEO) News Today $4.46 +0.15 (+3.36%) As of 03:55 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Abeona Therapeutics Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Abeona Therapeutics Inc. (ABEO) - What Are Analysts Saying About This Stock?October 13, 2026 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOOctober 6, 2026 | globenewswire.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | globenewswire.comIl SVP di Abeona Therapeutics vende azioni per $34.681September 30, 2026 | it.investing.comIl CFO di Abeona Therapeutics Joseph Vazzano vende azioni per $47.385September 30, 2026 | it.investing.comAbeona Therapeutics (NASDAQ:ABEO) Stock: Insider Vishwas Seshadri Sells 19,608 SharesSeptember 30, 2026 | marketbeat.comInsider Selling: Abeona Therapeutics (NASDAQ:ABEO) Insider Sells 4,902 Shares of StockSeptember 30, 2026 | insidertrades.comInsider Selling: Abeona Therapeutics (NASDAQ:ABEO) Insider Sells 4,902 Shares of Company StockSeptember 29, 2026 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Stock: Insider Brendan O'malley Sells 6,727 SharesSeptember 29, 2026 | marketbeat.comInsider Selling: Abeona Therapeutics (NASDAQ:ABEO) CFO Sells 9,191 Shares of StockSeptember 29, 2026 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 29, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 24, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 22, 2026 | globenewswire.comAbeona Therapeutics (ABEO) Highlights FDA Approval Of FAYUVI Gene Therapy For MPS IIIASeptember 19, 2026 | rttnews.comAbeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)September 18, 2026 | globenewswire.comABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It SellsSeptember 17, 2026 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 17, 2026 | prnewswire.comAbeona Activates Eighth U.S. Testing Site For ZEVASKYN In Epidermolysis Bullosa; Stock DownSeptember 16, 2026 | rttnews.comAbeona Therapeutics Inc. (ABEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 16, 2026 | seekingalpha.comAbeona Therapeutics Activates University of Florida Health as Eighth Qualified Treatment Center for ZEVASKYN in RDEBSeptember 16, 2026 | quiverquant.comQAbeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®September 16, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 15, 2026 | globenewswire.comAbeona Therapeutics Updates Investor Presentation at ConferenceSeptember 15, 2026 | tipranks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 10, 2026 | prnewswire.comABEO Investors Have Opportunity to Join Abeona Therapeutics Inc. Fraud Investigation with SBS LawSeptember 8, 2026 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 8, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 3, 2026 | prnewswire.comAbeona Therapeutics® Announces Participation in Upcoming Investor ConferencesSeptember 2, 2026 | globenewswire.comMark Alvino Sells 15,000 Shares of Abeona Therapeutics (NASDAQ:ABEO) StockSeptember 2, 2026 | insidertrades.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOSeptember 1, 2026 | globenewswire.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 1, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOAugust 27, 2026 | prnewswire.comAbeona’s (ABEO) Gene Therapy Launch Hits A Pivotal Reimbursement MilestoneAugust 21, 2026 | finance.yahoo.comAbeona (ABEO) Q2 2026 Earnings Call TranscriptAugust 20, 2026 | finance.yahoo.comABEO: Zevaskyn® Launch Gains MomentumAugust 17, 2026 | finance.yahoo.comAbeona Therapeutics Inc. Q2 2026 Earnings Call SummaryAugust 14, 2026 | finance.yahoo.comAbeona Therapeutics Shares Fall After Q2 MissAugust 13, 2026 | finance.yahoo.comAbeona Therapeutics: Earnings Sell-Off Could Be A Buy OpportunityAugust 13, 2026 | seekingalpha.comAbeona drops after Q2 revenue missAugust 13, 2026 | msn.comAbeona Therapeutics Inc. (ABEO) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | seekingalpha.comAbeona Therapeutics Inc.: Abeona Therapeutics Reports Second Quarter 2026 Results and Provides Business UpdateAugust 13, 2026 | finanznachrichten.deAbeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business UpdateAugust 13, 2026 | globenewswire.comAbeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026August 6, 2026 | globenewswire.comCMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®August 4, 2026 | globenewswire.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 3, 2026 | globenewswire.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Abeona Therapeutics Inc. (NASDAQ: ABEO)July 27, 2026 | prnewswire.comCincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®July 21, 2026 | globenewswire.comBrendan O'malley Sells 12,050 Shares of Abeona Therapeutics (NASDAQ:ABEO) StockJuly 10, 2026 | insidertrades.comInsider Selling: Abeona Therapeutics (NASDAQ:ABEO) Director Sells 11,000 Shares of StockJuly 3, 2026 | insidertrades.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 1, 2026 | globenewswire.com Abeona Therapeutics Media Mentions By Week Abeona Therapeutics Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼0.000.60▲Average Healthcare News Sentiment Abeona Therapeutics News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼15▲ABEO Articles Average Week Abeona Therapeutics Trends on MarketBeatThis week vs. last weekNew Followers1Searches2-60%Page Views1,885-14% Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Immatics News Odyssey Therapeutics News Jade Biosciences News Monte Rosa Therapeutics News Cullinan Therapeutics News Verastem News Rigel Pharmaceuticals News Corvus Pharmaceuticals News MeiraGTx News Alumis News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Abeona Therapeutics dated 10/13/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
